Last reviewed · How we verify

NCT05015777

Effects of Jaques-Dalcroze Eurhythmics Program on Postural Stability in Elderly Women.

Completed NA Last updated 20 August 2021
What this trial tests

NA trial testing Emil Jaques-Dalcroze's Eurhythimcs Exercise Program in Aging Problems in 71 participants. Completed in 20 June 2016.

Timeline
6 March 2016
Primary endpoint
20 June 2016
20 June 2016

Quick facts

Lead sponsorPoznan University of Physical Education
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment71
Start date6 March 2016
Primary completion20 June 2016
Estimated completion20 June 2016
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Poznan University of Physical Education

Who can join

65 and older, female only, with Aging Problems or Coordination Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigated the effect of exercise using the Emil Jaques-Dalcroze's method on the postural stability of women over 65 years of age. The study model was based on a randomized controlled trial - parallel group design.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of Jaques-Dalcroze eurhythmics program on postural stability in elderly women.
    Adamczyk J, Celka R, Stemplewski R, Ceynowa K, et al · · 2022 · cited 3× · PMID 35490165 · DOI 10.1038/s41598-022-11095-x

Verify or expand the search:

Other recruiting trials for Aging Problems

Currently open trials in the same condition.

Other Poznan University of Physical Education trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05015777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing